Polyfunctionality is a hallmark of protective immunity, yet the molecular mechanisms governing polyfunctional T cells are poorly understood. After TCR activation, naïve CD8^+^T cells undergo proliferation and differentiation, which lead to effector functions and memory subset development. However only a portion of activated T cells develop into memory CD8^+^T cells and with chronic stimulation become terminally differentiated and exhausted CD8^+^T cells, as defined by CCR7^-^/CD45RA^+^, and functionally impair effective immune responses \[[@B1]\]. We therefore probed the ability to reverse terminally differentiated antigen-specific cells using pharmacological agents. Stimulating human memory CD8^+^T cells with cognate TCR stimulation in the presence of Wnt agonist enhances polyfunctionality and stemness. Both M1-influenza^+^and CMV^+^CD8^+^T cell responses were reprogrammed and revealed sustained effects from initial Wnt pathway activation *in vitro*. Future work with cancer antigens and reprogramming of differentiated CD8^+^responses could lead to improved *in vitro*culture conditions for adoptive immunotherapy.
